| Autor: |
Meyer, Claudia, Dierick, Ines, Gauderat, Glenn, Langenhorst, Jurgen, Sarr, Céline, Leroux, Emilie, Chenel, Marylore, Fouliard, Sylvain, Passier, Paul |
| Předmět: |
|
| Zdroj: |
Clinical Pharmacology & Therapeutics; Feb2023, Vol. 113 Issue 2, p310-320, 11p |
| Abstrakt: |
During development of a drug, the requirement of evaluating the proarrhythmic risk and delayed repolarization needs to be fulfilled. Would it be possible to create an alternative to a thorough QT (TQT) study or is there a need to perform a dedicated TQT study? How is an alternative approach generated, what information is available, and which instructions are considered missing today to generate such an approach? This tutorial describes the considerations and path followed to create an early and feasible alternative to a TQT study using experience‐based insights from a successful application to the US Food and Drug Administration for GLPG1972, an ADAMTS‐5 inhibitor, and discusses the approach used in light of the current guidelines and literature. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text